0001104659-21-119384.txt : 20210924 0001104659-21-119384.hdr.sgml : 20210924 20210924172331 ACCESSION NUMBER: 0001104659-21-119384 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210831 FILED AS OF DATE: 20210924 DATE AS OF CHANGE: 20210924 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Litchman Manuel MD CENTRAL INDEX KEY: 0001709485 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38191 FILM NUMBER: 211278315 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MUSTANG BIO, INC. CENTRAL INDEX KEY: 0001680048 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473828760 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 7816524507 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 4 1 tm2128458-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-08-31 0 0001680048 MUSTANG BIO, INC. MBIO 0001709485 Litchman Manuel MD 377 PLANTATION STREET WORCESTER MA 01605 1 1 0 0 President and CEO COMMON STOCK 2021-08-31 4 A 0 2746 2.58 A 962987 D These shares were acquired under the Mustang Bio, Inc. Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on March 1, 2021 and ending on August 31, 2021 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's ordinary shares on August 31, 2021 (the purchase date of the offering period). Includes restricted stock units, which vest over various time periods. /s/ Manuel Litchman 2021-09-24